Key result
The FMDV 2A peptide enables the coordinated co-expression of up to four proteins from a single vector, offering a more balanced and compact alternative to internal ribosomal entry sites.
Answers are grounded in this paper and cite their sources.
The 2A peptide provides a compact and efficient alternative to IRESs for co-expressing multiple proteins from a single vector in gene therapy applications.
The rapid progress in the field of genomics is increasing our knowledge of multi-gene diseases. However, any realistic hope of gene therapy treatment for those diseases needs first to address the problem of co-ordinately co-expressing several transgenes. Currently, the use of internal ribosomal entry sites (IRESs) is the strategy chosen by many researchers to ensure co-expression. The large sizes of the IRESs (~0.5 kb), and the difficulties of ensuring a well-balanced co-expression, have prompted several researchers to imitate a co-expression strategy used by many viruses: to express several proteins as a polyprotein. A small peptide of 18 amino acids (2A) from the foot-and-mouth disease virus (FMDV) is being used to avoid the need of proteinases to process the polyprotein. FMDV 2A is introduced as a linker between two proteins to allow autonomous intra-ribosomal self-processing of polyproteins. Recent reports have shown that this sequence is compatible with different sub-cellular targeting signals and can be used to co-express up to four proteins from a single retroviral vector. This short peptide provides a tool to allow the co-expression of multiple proteins from a single vector, a useful technology for those working with heteromultimeric proteins, biochemical pathways or combined/synergistic phenomena.
No takes yet. Share an insight, caveat, or question.
Pablo de Felipe (2004) conducted a review in Multi-gene diseases requiring gene therapy. FMDV 2A "CHYSEL" technology vs. Internal ribosomal entry sites (IRESs) was evaluated. The FMDV 2A peptide enables the coordinated co-expression of up to four proteins from a single vector, offering a more balanced and compact alternative to internal ribosomal entry sites.
Synapse has enriched 10 related papers. Consider them for comparative context: